본문으로 건너뛰기
← 뒤로

Pseudotumoral Pulmonary Disease in a Patient on Ruxolitinib Therapy.

2/5 보강
Diagnostics (Basel, Switzerland) 📖 저널 OA 100% 2021: 4/4 OA 2022: 16/16 OA 2023: 20/20 OA 2024: 45/45 OA 2025: 135/135 OA 2026: 136/136 OA 2021~2026 2026 Vol.16(7) OA Mycobacterium research and diagnosis
Retraction 확인
출처
PubMed DOI PMC OpenAlex 마지막 보강 2026-04-30
OpenAlex 토픽 · Mycobacterium research and diagnosis Diagnosis and treatment of tuberculosis Tuberculosis Research and Epidemiology

Constantin AA, Iorga AL, Gaburici AD, Leonte I

📝 환자 설명용 한 줄

Pulmonary disease caused by nontuberculous mycobacteria represents an important diagnostic challenge, particularly in immunocompromised patients, in whom clinical and radiologic findings may mimic mal

이 논문을 인용하기

↓ .bib ↓ .ris
APA Ancuța Constantin, Ana-Luiza Iorga, et al. (2026). Pseudotumoral Pulmonary Disease in a Patient on Ruxolitinib Therapy.. Diagnostics (Basel, Switzerland), 16(7). https://doi.org/10.3390/diagnostics16071069
MLA Ancuța Constantin, et al.. "Pseudotumoral Pulmonary Disease in a Patient on Ruxolitinib Therapy.." Diagnostics (Basel, Switzerland), vol. 16, no. 7, 2026.
PMID 41975780 ↗

Abstract

Pulmonary disease caused by nontuberculous mycobacteria represents an important diagnostic challenge, particularly in immunocompromised patients, in whom clinical and radiologic findings may mimic malignancy. We report the case of a 70-year-old woman with myelofibrosis treated with ruxolitinib who developed a tumor-like lesion in the left upper lobe on computed tomography, highly suggestive of lung cancer. Despite broad-spectrum antibiotic therapy, the lesion persisted; bronchoscopy did not yield diagnostic findings, and CT-guided transthoracic biopsy demonstrated necrotizing granulomatous inflammation without evidence of malignancy. Microbiological analysis subsequently identified , and targeted antimycobacterial therapy led to clinical and radiologic improvement. This case highlights that pulmonary nontuberculous mycobacterial infection may present as a pseudotumoral lesion and should be considered in the differential diagnosis of mass-like pulmonary opacities, particularly in patients receiving Janus kinase inhibitor therapy.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기